Methods: In the retrospective real-world study, which included 93 adults without diabetes (57% women, average age 52 years), we assessed whether treatment with 14 mg oral semaglutide over one year is associated with lower body weight, body mass index (BMI), waist circumference, blood pressure, heart rate, and obesity staging according to EOSS
For weight management, the dosage typically starts low to minimize side effects, with gradual increases
Vitamin K2 as MK-7 for its longer half-life and superior bioavailability
Symptoms of hypoglycaemia : Such as sweating, tremor, confusion, or palpitations, especially if recurrent
Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3